Sandbox: ATL: Difference between revisions

Jump to navigation Jump to search
(Created page with "HTLV-1 infection in the United States appears to be rare. Although little serologic data exist, prevalence of infection is thought to be highest among blacks living in the So...")
 
No edit summary
Line 1: Line 1:
HTLV-1 infection in the United States appears to be rare.  
HTLV-1 infection in the United States appears to be rare.  
Although little serologic data exist, prevalence of infection is thought to be highest among blacks living in the Southeast.  
Prevalence of infection is thought to be highest among blacks living in the Southeast.  
A prevalence rate of 30% has been found among black intravenous drug abusers in New Jersey, and a rate of 49% has been found in a similar group in New Orleans.  
A prevalence rate of 30% has been found among black intravenous drug abusers in New Jersey, and a rate of 49% has been found in a similar group in New Orleans.  
It is possible that prevalence of infection is increasing in this risk group.  
It is possible that prevalence of infection is increasing in this risk group.  
Studies of HTLV-1 antibody indicate that the virus is endemic in southern Japan, in the Caribbean, South America, and in Africa.


 
southern Japan, in the Caribbean, South America, and in Africa.
ATL is relatively uncommon among those infected with HTLV-1.  
The overall incidence of ATL is estimated at about 1 per 1,500 adult HTLV-1 carriers per year.
The overall incidence of ATL is estimated at about 1 per 1,500 adult HTLV-1 carriers per year.
Those cases that have been reported have occurred mostly among persons from the Caribbean or blacks from the Southeast (National Institutes of Health, unpublished data).
There appears to be a long latent period between HTLV-1 infection and the start of ATL.

Revision as of 19:33, 22 January 2016

HTLV-1 infection in the United States appears to be rare. Prevalence of infection is thought to be highest among blacks living in the Southeast. A prevalence rate of 30% has been found among black intravenous drug abusers in New Jersey, and a rate of 49% has been found in a similar group in New Orleans. It is possible that prevalence of infection is increasing in this risk group.

southern Japan, in the Caribbean, South America, and in Africa.

The overall incidence of ATL is estimated at about 1 per 1,500 adult HTLV-1 carriers per year.